HYALURONIC ACID

HYALURONIC ACID was reported 1176 times

HYALURONIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DERMAL FILLER INJECTION 1 0.5000
1 ANTERIOR SEGMENT ISCHAEMIA 4 0.2105
2 ANTI-SRP ANTIBODY POSITIVE 1 0.1111
3 ANTERIOR CHAMBER PIGMENTATION 2 0.1000
4 DERMAL FILLER REACTION 1 0.1000
5 EXTRUSION OF DEVICE 1 0.0714
6 AIRWAY SECRETION CLEARANCE THERAPY 1 0.0667
7 CERVICAL SPINAL CORD PARALYSIS 1 0.0476
8 IRIS HYPOPIGMENTATION 4 0.0374
9 PIGMENT DISPERSION SYNDROME 3 0.0316
10 DIABETIC MACROANGIOPATHY 1 0.0303
11 CHONDROMATOSIS 1 0.0263
12 PERIORBITAL INFECTION 2 0.0247
13 TONGUE ROUGH 2 0.0235
14 DEVICE LEAD DAMAGE 1 0.0208
15 HERPES SIMPLEX TEST POSITIVE 4 0.0201
16 CONJUNCTIVAL BLEB 1 0.0185
17 BLEPHAROPLASTY 2 0.0164
18 FACE LIFT 1 0.0161
19 OCULAR PEMPHIGOID 2 0.0160
20 EXERTIONAL HEADACHE 1 0.0156
21 EYELID CONTUSION 1 0.0149
22 FEMORAL HERNIA INCARCERATED 1 0.0139
23 ANAL SPASM 1 0.0130
24 LAGOPHTHALMOS 5 0.0122
25 CONNECTIVE TISSUE INFLAMMATION 1 0.0105
26 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
27 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 4 0.0102
28 PUPILLARY DISORDER 6 0.0099
29 INJECTION SITE PLAQUE 2 0.0095
30 HYPERCREATINAEMIA 3 0.0091
31 PORTAL HYPERTENSIVE GASTROPATHY 5 0.0089
32 FOREIGN BODY REACTION 2 0.0081
33 NOSE DEFORMITY 3 0.0081
34 MICROSCOPIC POLYANGIITIS 2 0.0077
35 MORAXELLA INFECTION 2 0.0073
36 CONGENITAL MITRAL VALVE INCOMPETENCE 1 0.0071
37 CHONDROMALACIA 2 0.0070
38 BONE LESION EXCISION 1 0.0066
39 BIOPSY SITE UNSPECIFIED ABNORMAL 1 0.0066
40 DACRYOCYSTITIS 1 0.0065
41 NAIL BED INFLAMMATION 2 0.0063
42 BRACHIAL PLEXUS INJURY 1 0.0062
43 EYELID BLEEDING 1 0.0058
44 PRODUCT ADMINISTERED BY WRONG PERSON 2 0.0052
45 EJECTION FRACTION 3 0.0052
46 ARTHROSCOPIC SURGERY 1 0.0050
47 PERINEAL ABSCESS 2 0.0044
48 CRANIOFACIAL DEFORMITY 1 0.0043
49 INJECTION SITE ULCER 4 0.0042
50 RETINAL VASCULITIS 5 0.0042
51 SENSITISATION 3 0.0040
52 BACTEROIDES INFECTION 1 0.0038
53 TOXIC ANTERIOR SEGMENT SYNDROME 4 0.0037
54 EYELID THICKENING 1 0.0035
55 LEGIONELLA INFECTION 2 0.0035
56 ABDOMINAL WALL DISORDER 1 0.0034
57 DENTAL NECROSIS 1 0.0034
58 PNEUMOCOCCAL INFECTION 2 0.0034
59 LIMB MASS 7 0.0032
60 CORNEAL PERFORATION 2 0.0032
61 LIPOATROPHY 3 0.0032
62 RETINAL DEGENERATION 4 0.0031
63 INJECTION SITE NECROSIS 6 0.0029
64 CUBITAL TUNNEL SYNDROME 1 0.0029
65 CONJUNCTIVITIS BACTERIAL 1 0.0029
66 FAT EMBOLISM 1 0.0028
67 BODY DYSMORPHIC DISORDER 1 0.0027
68 LIP DISORDER 5 0.0026
69 FAT TISSUE DECREASED 1 0.0026
70 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
71 EMBOLIA CUTIS MEDICAMENTOSA 2 0.0025
72 DISEASE RISK FACTOR 1 0.0025
73 ANHIDROSIS 1 0.0025
74 EJECTION FRACTION ABNORMAL 3 0.0024
75 TONGUE ERYTHEMA 2 0.0024
76 BOTULISM 2 0.0024
77 COVID-19 IMMUNISATION 2 0.0024
78 CUTANEOUS SARCOIDOSIS 1 0.0023
79 BULIMIA NERVOSA 1 0.0023
80 EYELID INFECTION 1 0.0023
81 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
82 TONGUE DRY 3 0.0022
83 ECZEMA HERPETICUM 1 0.0022
84 FACIAL ASYMMETRY 2 0.0021
85 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
86 BODY HEIGHT INCREASED 1 0.0020
87 JOINT NOISE 4 0.0020
88 ARTIFICIAL CROWN PROCEDURE 1 0.0020
89 FACIAL PARESIS 7 0.0020
90 ACCIDENT AT HOME 1 0.0019
91 POLYCYSTIC OVARIES 3 0.0019
92 FAECAL VOLUME INCREASED 1 0.0019
93 OEDEMA MUCOSAL 2 0.0019
94 BURSITIS INFECTIVE 1 0.0018
95 ULCERATIVE KERATITIS 5 0.0018
96 LISTERIOSIS 2 0.0018
97 COLLAGEN DISORDER 1 0.0017
98 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
99 OSTEOCHONDROSIS 2 0.0017
100 AMBLYOPIA 1 0.0017
101 ENDOSCOPY 1 0.0017
102 VARICES OESOPHAGEAL 5 0.0017
103 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
104 EYE OEDEMA 4 0.0016
105 POST-ACUTE COVID-19 SYNDROME 2 0.0016
106 DYSPAREUNIA 7 0.0015
107 CATARACT NUCLEAR 1 0.0015
108 DEFAECATION DISORDER 1 0.0015
109 ABSCESS NECK 1 0.0015
110 EXTRAVASATION 6 0.0015
111 DISCHARGE 2 0.0014
112 PERIODONTAL DISEASE 2 0.0014
113 VASCULAR OCCLUSION 3 0.0014
114 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
115 CERVICAL RADICULOPATHY 1 0.0014
116 NAIL INFECTION 2 0.0014
117 ATROPHIC VULVOVAGINITIS 1 0.0014
118 STRABISMUS 4 0.0014
119 CORNEAL DEPOSITS 1 0.0013
120 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
121 CHOLANGITIS ACUTE 1 0.0013
122 HAEMATOCRIT INCREASED 3 0.0013
123 PNEUMONIA PSEUDOMONAL 2 0.0013
124 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
125 EXTRADURAL ABSCESS 1 0.0013
126 OPHTHALMOPLEGIA 2 0.0013
127 SKIN TOXICITY 7 0.0012
128 MEDICAL PROCEDURE 2 0.0012
129 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
130 DEAFNESS TRANSITORY 1 0.0012
131 CRANIOFACIAL FRACTURE 1 0.0012
132 CHOROIDAL NEOVASCULARISATION 1 0.0012
133 THYROIDECTOMY 2 0.0012
134 INDURATION 2 0.0011
135 ANAEMIA OF CHRONIC DISEASE 1 0.0011
136 RASH MORBILLIFORM 3 0.0011
137 ARTHRITIS INFECTIVE 5 0.0011
138 BONE GRAFT 1 0.0011
139 BONE CYST 1 0.0011
140 NARCOLEPSY 2 0.0011
141 SKIN ATROPHY 6 0.0010
142 APPLICATION SITE BRUISE 1 0.0010
143 NAIL DISORDER 9 0.0010
144 INJECTION SITE INFLAMMATION 5 0.0010
145 HYPOPHYSITIS 2 0.0010
146 MUSCLE CONTRACTURE 2 0.0010
147 EYE COLOUR CHANGE 1 0.0010
148 BODY TEMPERATURE FLUCTUATION 2 0.0010
149 COGWHEEL RIGIDITY 1 0.0010
150 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
151 INJECTION SITE INDENTATION 2 0.0009
152 BLADDER DILATATION 1 0.0009
153 PEPTIC ULCER 3 0.0009
154 FACIAL SPASM 1 0.0009
155 PERIARTHRITIS 2 0.0009
156 CHEMICAL BURN 1 0.0009
157 NERVE COMPRESSION 8 0.0009
158 SKIN TIGHTNESS 4 0.0008
159 NODULE 11 0.0008
160 WEIGHT ABNORMAL 2 0.0008
161 EYELID SKIN DRYNESS 1 0.0008
162 ALLERGY TO CHEMICALS 1 0.0008
163 TACHYARRHYTHMIA 2 0.0008
164 OSTEITIS 2 0.0008
165 PARANASAL SINUS DISCOMFORT 3 0.0008
166 FACE INJURY 3 0.0008
167 RESPIRATORY RATE INCREASED 7 0.0008
168 INCREASED BRONCHIAL SECRETION 2 0.0008
169 LACTOSE INTOLERANCE 2 0.0008
170 ADENOCARCINOMA PANCREAS 1 0.0008
171 AORTIC ARTERIOSCLEROSIS 2 0.0008
172 DACRYOSTENOSIS ACQUIRED 1 0.0008
173 LIPOMA 2 0.0008
174 PERIORBITAL OEDEMA 4 0.0008
175 ADJUSTMENT DISORDER 1 0.0008
176 TENDERNESS 8 0.0008
177 PRODUCT PREPARATION ISSUE 5 0.0008
178 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
179 CYSTITIS NONINFECTIVE 1 0.0007
180 CHONDROPATHY 2 0.0007
181 CALCULUS BLADDER 1 0.0007
182 ORAL FUNGAL INFECTION 2 0.0007
183 CORNEAL ABRASION 1 0.0007
184 DRUG TOLERANCE DECREASED 2 0.0007
185 BODY TEMPERATURE DECREASED 7 0.0007
186 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
187 PERIORBITAL SWELLING 4 0.0007
188 INJECTION SITE SCAR 2 0.0007
189 LIP PAIN 2 0.0007
190 HERPES VIRUS INFECTION 4 0.0007
191 EYELID PTOSIS 7 0.0007
192 GINGIVAL SWELLING 3 0.0007
193 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
194 RHINITIS ALLERGIC 3 0.0007
195 AXILLARY PAIN 1 0.0007
196 FACIAL PAIN 6 0.0007
197 KERATITIS 2 0.0007
198 HAEMOGLOBIN INCREASED 3 0.0007
199 PROCEDURAL COMPLICATION 5 0.0007
200 INCREASED TENDENCY TO BRUISE 6 0.0007
201 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
202 FAMILY STRESS 2 0.0006
203 MASS 9 0.0006
204 NEPHROPATHY 6 0.0006
205 INFUSION SITE PRURITUS 2 0.0006
206 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
207 SUBCUTANEOUS ABSCESS 3 0.0006
208 EXPOSURE TO TOXIC AGENT 2 0.0006
209 GASTROINTESTINAL TOXICITY 3 0.0006
210 VULVOVAGINAL DRYNESS 2 0.0006
211 DENTAL IMPLANTATION 1 0.0006
212 PRODUCT FORMULATION ISSUE 4 0.0006
213 COLONIC POLYP 1 0.0006
214 SKIN MASS 4 0.0006
215 ERYSIPELAS 3 0.0006
216 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
217 TONGUE ULCERATION 2 0.0006
218 EXPOSURE TO SARS-COV-2 1 0.0006
219 PRODUCT PREPARATION ERROR 12 0.0006
220 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
221 PERIPHERAL COLDNESS 8 0.0006
222 CHOREA 1 0.0006
223 EAR PRURITUS 2 0.0006
224 HAEMORRHAGIC DIATHESIS 2 0.0006
225 APPLICATION SITE DISCOMFORT 1 0.0006
226 ESSENTIAL HYPERTENSION 1 0.0005
227 ORAL DISORDER 4 0.0005
228 BODY TEMPERATURE ABNORMAL 1 0.0005
229 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
230 DENTAL CARE 1 0.0005
231 NEURODERMATITIS 2 0.0005
232 BLOOD CHOLESTEROL DECREASED 1 0.0005
233 BONE DENSITY ABNORMAL 2 0.0005
234 CYSTOID MACULAR OEDEMA 1 0.0005
235 HEPATOCELLULAR CARCINOMA 4 0.0005
236 GASTRIC INFECTION 2 0.0005
237 CONVERSION DISORDER 1 0.0005
238 ATROPHY 1 0.0005
239 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
240 ORAL INFECTION 2 0.0005
241 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
242 DIPLEGIA 1 0.0005
243 ANORECTAL DISORDER 1 0.0005
244 BLEPHARITIS 2 0.0005
245 CYSTITIS HAEMORRHAGIC 2 0.0005
246 NOCTURIA 6 0.0005
247 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
248 APPLICATION SITE DISCOLOURATION 2 0.0005
249 EYELID PAIN 1 0.0005
250 MENISCUS INJURY 3 0.0005
251 APPLICATION SITE EXFOLIATION 2 0.0005
252 EYE DISCHARGE 5 0.0005
253 SECOND PRIMARY MALIGNANCY 4 0.0005
254 PHOTOPSIA 3 0.0005
255 EYE CONTUSION 1 0.0005
256 FOREIGN BODY SENSATION IN EYES 3 0.0005
257 POOR PERIPHERAL CIRCULATION 2 0.0005
258 FACIAL PARALYSIS 4 0.0005
259 BODY HEIGHT DECREASED 5 0.0005
260 MUSCLE STRAIN 4 0.0005
261 HORDEOLUM 2 0.0005
262 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
263 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
264 CORNEAL DISORDER 1 0.0005
265 PARONYCHIA 2 0.0005
266 DIABETIC NEPHROPATHY 1 0.0005
267 COLONOSCOPY 1 0.0005
268 VULVOVAGINAL DISCOMFORT 2 0.0005
269 BACTERIAL TEST POSITIVE 1 0.0004
270 CORNEAL OEDEMA 1 0.0004
271 ABDOMINAL HERNIA 2 0.0004
272 HAIR GROWTH ABNORMAL 3 0.0004
273 SYNOVIAL CYST 2 0.0004
274 FORMICATION 3 0.0004
275 MADAROSIS 5 0.0004
276 BLOOD TEST ABNORMAL 6 0.0004
277 OSTEOARTHRITIS 18 0.0004
278 HAND FRACTURE 3 0.0004
279 HYPERTHYROIDISM 6 0.0004
280 FINGER DEFORMITY 2 0.0004
281 DIZZINESS POSTURAL 4 0.0004
282 INTENTIONAL UNDERDOSE 3 0.0004
283 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
284 VITREOUS FLOATERS 4 0.0004
285 BLINDNESS TRANSIENT 3 0.0004
286 DENTAL OPERATION 1 0.0004
287 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
288 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
289 HYPOTONIA 4 0.0004
290 EYE DISORDER 13 0.0004
291 ENDODONTIC PROCEDURE 1 0.0004
292 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
293 DIABETIC COMPLICATION 1 0.0004
294 CANCER PAIN 1 0.0004
295 LIP SWELLING 13 0.0004
296 MYDRIASIS 5 0.0004
297 CACHEXIA 2 0.0004
298 APHTHOUS ULCER 3 0.0004
299 SWELLING FACE 25 0.0004
300 PETECHIAE 4 0.0004
301 BRAIN FOG 6 0.0004
302 AFFECTIVE DISORDER 3 0.0004
303 NASAL DISCOMFORT 3 0.0004
304 EYE SWELLING 14 0.0004
305 AREFLEXIA 1 0.0004
306 ANAL FISSURE 2 0.0004
307 ERYTHEMA OF EYELID 2 0.0004
308 ANORGASMIA 1 0.0004
309 SLEEP APNOEA SYNDROME 7 0.0004
310 CLUMSINESS 1 0.0004
311 DEAFNESS UNILATERAL 2 0.0004
312 CHOKING SENSATION 2 0.0004
313 EAR PAIN 7 0.0004
314 TOOTH DISORDER 8 0.0004
315 INTERMENSTRUAL BLEEDING 2 0.0004
316 ORAL PAIN 8 0.0004
317 ANAL HAEMORRHAGE 1 0.0004
318 CARPAL TUNNEL SYNDROME 5 0.0004
319 OCULAR DISCOMFORT 4 0.0004
320 SKIN REACTION 5 0.0004
321 DERMATITIS CONTACT 4 0.0004
322 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
323 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
324 ESCHERICHIA SEPSIS 1 0.0003
325 ELECTROLYTE IMBALANCE 4 0.0003
326 SKIN WARM 2 0.0003
327 GROIN PAIN 3 0.0003
328 SPINAL OSTEOARTHRITIS 3 0.0003
329 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
330 GOUT 6 0.0003
331 KNEE ARTHROPLASTY 7 0.0003
332 HEPATITIS CHOLESTATIC 2 0.0003
333 ACNE CYSTIC 1 0.0003
334 HEPATITIS B 2 0.0003
335 CEREBROVASCULAR DISORDER 1 0.0003
336 EYE INJURY 1 0.0003
337 FIBROSIS 1 0.0003
338 BRAIN DEATH 1 0.0003
339 CONJUNCTIVITIS 6 0.0003
340 FEELING COLD 9 0.0003
341 EYELIDS PRURITUS 1 0.0003
342 PRE-EXISTING CONDITION IMPROVED 2 0.0003
343 SECRETION DISCHARGE 4 0.0003
344 NASAL DRYNESS 2 0.0003
345 DRUG EFFECT INCREASED 1 0.0003
346 THERAPEUTIC RESPONSE CHANGED 2 0.0003
347 EYE INFLAMMATION 3 0.0003
348 GLAUCOMA 6 0.0003
349 SKIN ULCER 8 0.0003
350 CARDIAC FLUTTER 2 0.0003
351 HAEMORRHOIDS 6 0.0003
352 TENDON DISORDER 2 0.0003
353 SOMNAMBULISM 2 0.0003
354 BLOOD UREA INCREASED 5 0.0003
355 QUALITY OF LIFE DECREASED 4 0.0003
356 FULL BLOOD COUNT DECREASED 6 0.0003
357 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
358 APPLICATION SITE DRYNESS 1 0.0003
359 B-CELL LYMPHOMA 1 0.0003
360 DIABETIC RETINOPATHY 1 0.0003
361 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
362 EAR DISCOMFORT 3 0.0003
363 ONYCHOCLASIS 2 0.0003
364 JOINT EFFUSION 2 0.0003
365 AORTIC STENOSIS 1 0.0003
366 BURNING SENSATION 20 0.0003
367 PAPULE 2 0.0003
368 COLD SWEAT 5 0.0003
369 FULL BLOOD COUNT ABNORMAL 3 0.0003
370 EYE PAIN 16 0.0003
371 DUODENAL ULCER 2 0.0003
372 LYMPHOPENIA 4 0.0003
373 BONE EROSION 1 0.0003
374 SEASONAL ALLERGY 4 0.0003
375 THERMAL BURN 2 0.0003
376 CONJUNCTIVAL HYPERAEMIA 1 0.0003
377 DRY EYE 14 0.0003
378 FACIAL BONES FRACTURE 1 0.0003
379 PHARYNGITIS STREPTOCOCCAL 3 0.0003
380 DERMATITIS BULLOUS 2 0.0003
381 TOOTHACHE 5 0.0003
382 INJECTION SITE HAEMATOMA 4 0.0003
383 FOOD INTOLERANCE 1 0.0003
384 INJECTION SITE NODULE 3 0.0003
385 VISUAL ACUITY REDUCED 9 0.0003
386 SKIN HAEMORRHAGE 4 0.0003
387 SKIN INFECTION 3 0.0003
388 OSTEOPOROSIS 11 0.0003
389 SWELLING 25 0.0003
390 PHOTOPHOBIA 5 0.0003
391 EYE INFECTION 3 0.0003
392 BOWEL MOVEMENT IRREGULARITY 2 0.0003
393 EYELID OEDEMA 3 0.0003
394 FAECES HARD 1 0.0003
395 LYMPHADENOPATHY 9 0.0003
396 CANDIDIASIS 1 0.0002
397 SENSORY DISTURBANCE 4 0.0002
398 RHINITIS 2 0.0002
399 ENURESIS 1 0.0002
400 FRUSTRATION TOLERANCE DECREASED 2 0.0002
401 PRODUCT ADMINISTRATION ERROR 5 0.0002
402 FIBROMYALGIA 6 0.0002
403 DISCOMFORT 15 0.0002
404 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
405 GENERALISED OEDEMA 3 0.0002
406 PHARYNGITIS 3 0.0002
407 EOSINOPHIL COUNT INCREASED 2 0.0002
408 HYPOKALAEMIA 11 0.0002
409 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
410 MUSCLE ATROPHY 3 0.0002
411 INJECTION SITE IRRITATION 3 0.0002
412 SKIN HYPERPIGMENTATION 2 0.0002
413 ABNORMAL SENSATION IN EYE 1 0.0002
414 ANURIA 2 0.0002
415 LACRIMATION INCREASED 7 0.0002
416 INJECTION SITE INDURATION 3 0.0002
417 PYELONEPHRITIS 2 0.0002
418 SKIN SWELLING 2 0.0002
419 LOCAL SWELLING 4 0.0002
420 DIVERTICULUM INTESTINAL 1 0.0002
421 TOOTH INFECTION 3 0.0002
422 APPLICATION SITE PAIN 5 0.0002
423 BLOOD CREATINE INCREASED 1 0.0002
424 RASH MACULO-PAPULAR 5 0.0002
425 THIRST 4 0.0002
426 HAEMARTHROSIS 2 0.0002
427 GASTROINTESTINAL INFECTION 2 0.0002
428 THERAPY NON-RESPONDER 10 0.0002
429 HEAVY MENSTRUAL BLEEDING 2 0.0002
430 SINUS CONGESTION 3 0.0002
431 DRY MOUTH 18 0.0002
432 NEUROPATHY PERIPHERAL 21 0.0002
433 TACHYPNOEA 3 0.0002
434 LIP DRY 2 0.0002
435 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
436 GINGIVAL BLEEDING 3 0.0002
437 EXOSTOSIS 2 0.0002
438 SKIN LESION 6 0.0002
439 DISEASE COMPLICATION 1 0.0002
440 EAR DISORDER 1 0.0002
441 CONTUSION 21 0.0002
442 PNEUMONIA BACTERIAL 2 0.0002
443 SKIN DISCOLOURATION 10 0.0002
444 INJECTION SITE MASS 8 0.0002
445 DEFORMITY 2 0.0002
446 LACERATION 2 0.0002
447 ARTERIOSCLEROSIS 2 0.0002
448 SPINAL DISORDER 2 0.0002
449 SPUTUM DISCOLOURED 2 0.0002
450 SKIN DISORDER 7 0.0002
451 IMPAIRED QUALITY OF LIFE 3 0.0002
452 POST PROCEDURAL COMPLICATION 4 0.0002
453 ENTEROCOCCAL INFECTION 1 0.0002
454 APATHY 3 0.0002
455 NEURALGIA 5 0.0002
456 ARTHRALGIA 85 0.0002
457 ARTHRITIS 16 0.0002
458 THERAPY CHANGE 2 0.0002
459 KNEE OPERATION 2 0.0002
460 DIABETIC NEUROPATHY 1 0.0002
461 BLOOD PRESSURE ABNORMAL 4 0.0002
462 HYPOAESTHESIA ORAL 3 0.0002
463 JOINT SWELLING 24 0.0002
464 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
465 APHASIA 6 0.0002
466 TASTE DISORDER 4 0.0002
467 BLINDNESS 8 0.0002
468 CHILLS 23 0.0002
469 INSURANCE ISSUE 3 0.0002
470 INJECTION SITE SWELLING 15 0.0002
471 THYROID DISORDER 3 0.0002
472 LIMB DISCOMFORT 6 0.0002
473 TENDONITIS 3 0.0002
474 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
475 RHABDOMYOLYSIS 8 0.0002
476 APLASTIC ANAEMIA 1 0.0002
477 WEIGHT FLUCTUATION 2 0.0002
478 PRODUCT USE COMPLAINT 3 0.0002
479 GASTRITIS 5 0.0002
480 RESPIRATORY TRACT CONGESTION 3 0.0002
481 ANORECTAL DISCOMFORT 1 0.0002
482 BREAST CANCER METASTATIC 2 0.0002
483 DYSARTHRIA 7 0.0002
484 HOT FLUSH 14 0.0002
485 ANAL ABSCESS 1 0.0002
486 BRUXISM 1 0.0002
487 CHEILITIS 1 0.0002
488 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
489 WOUND INFECTION 2 0.0002
490 MANIA 3 0.0002
491 ASTHENOPIA 1 0.0002
492 ARTHROPATHY 10 0.0002
493 NERVE INJURY 2 0.0002
494 FACE OEDEMA 3 0.0002
495 REBOUND EFFECT 2 0.0002
496 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
497 PRODUCT AVAILABILITY ISSUE 4 0.0002
498 SINUSITIS 18 0.0002
499 INTENTIONAL DOSE OMISSION 5 0.0002
500 SCAR 3 0.0002
501 MICTURITION URGENCY 2 0.0002
502 CARDIAC VALVE DISEASE 1 0.0002
503 EXERCISE TOLERANCE DECREASED 1 0.0002
504 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
505 SPEECH DISORDER 9 0.0002
506 ABDOMINAL PAIN UPPER 35 0.0002
507 ENERGY INCREASED 1 0.0002
508 BRADYKINESIA 1 0.0002
509 COVID-19 PNEUMONIA 2 0.0002
510 CATARACT OPERATION 1 0.0002
511 PRODUCTIVE COUGH 8 0.0002
512 VISION BLURRED 23 0.0002
513 ENDOPHTHALMITIS 1 0.0002
514 BLOOD PRESSURE FLUCTUATION 4 0.0002
515 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
516 THYROID CANCER 2 0.0002
517 INFUSION RELATED REACTION 11 0.0002
518 LEUKOCYTOSIS 3 0.0002
519 BURSITIS 2 0.0002
520 MYALGIA 28 0.0002
521 RESPIRATORY FAILURE 12 0.0002
522 PRESYNCOPE 4 0.0002
523 DERMATITIS ACNEIFORM 1 0.0002
524 MUSCLE SPASMS 30 0.0002
525 INJECTION SITE RASH 5 0.0002
526 INJECTION SITE BRUISING 13 0.0002
527 ALOPECIA 32 0.0002
528 SPINAL OPERATION 2 0.0002
529 HEPATIC STEATOSIS 3 0.0002
530 AGEUSIA 4 0.0002
531 INJECTION SITE DISCOLOURATION 2 0.0002
532 INTENTIONAL PRODUCT MISUSE 14 0.0002
533 MUSCULOSKELETAL STIFFNESS 14 0.0002
534 COVID-19 28 0.0002
535 DERMATITIS ALLERGIC 2 0.0002
536 FLATULENCE 9 0.0002
537 MUSCULAR WEAKNESS 18 0.0002
538 FOOT FRACTURE 3 0.0002
539 NASOPHARYNGITIS 29 0.0002
540 ASTHENIA 59 0.0002
541 INTRAOCULAR PRESSURE INCREASED 2 0.0002
542 HYPOPHAGIA 4 0.0002
543 EYE IRRITATION 9 0.0002
544 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
545 ROTATOR CUFF SYNDROME 2 0.0002
546 MOVEMENT DISORDER 5 0.0002
547 ERYTHEMA 32 0.0002
548 HERNIA 3 0.0002
549 PRESCRIBED OVERDOSE 3 0.0002
550 APPLICATION SITE VESICLES 1 0.0002
551 ORAL HERPES 3 0.0002
552 SKIN FISSURES 3 0.0002
553 ABDOMINAL DISTENSION 16 0.0002
554 HAND DEFORMITY 2 0.0002
555 ASPERGILLUS INFECTION 1 0.0002
556 ORAL CANDIDIASIS 2 0.0002
557 IMMUNE SYSTEM DISORDER 2 0.0002
558 SINUS DISORDER 3 0.0002
559 OROPHARYNGEAL PAIN 14 0.0002
560 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
561 ADVERSE REACTION 2 0.0002
562 BLOOD PRESSURE INCREASED 23 0.0002
563 CARDIAC FAILURE ACUTE 1 0.0001
564 EYE HAEMORRHAGE 2 0.0001
565 URINARY RETENTION 5 0.0001
566 SPINAL FRACTURE 3 0.0001
567 EYE PRURITUS 5 0.0001
568 FEAR 4 0.0001
569 JAUNDICE 4 0.0001
570 BRONCHITIS 11 0.0001
571 OFF LABEL USE 130 0.0001
572 BRONCHIECTASIS 1 0.0001
573 THROAT TIGHTNESS 4 0.0001
574 OCULAR HYPERAEMIA 7 0.0001
575 LIMB INJURY 4 0.0001
576 PALLOR 4 0.0001
577 IMPAIRED GASTRIC EMPTYING 2 0.0001
578 BLOOD TESTOSTERONE DECREASED 1 0.0001
579 PARAESTHESIA 23 0.0001
580 EYE MOVEMENT DISORDER 1 0.0001
581 RESPIRATORY DISTRESS 4 0.0001
582 DROOLING 1 0.0001
583 AUTOIMMUNE HEPATITIS 1 0.0001
584 HUNGER 2 0.0001
585 PAIN 88 0.0001
586 SLEEP DISORDER 10 0.0001
587 PAIN IN JAW 4 0.0001
588 SINUS TACHYCARDIA 2 0.0001
589 DIVERTICULUM 1 0.0001
590 JOINT INJURY 3 0.0001
591 BRONCHOSPASM 2 0.0001
592 PARALYSIS 2 0.0001
593 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
594 CARDIAC DISORDER 13 0.0001
595 FAECES DISCOLOURED 3 0.0001
596 FAECES SOFT 1 0.0001
597 FATIGUE 107 0.0001
598 PANIC ATTACK 5 0.0001
599 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
600 GAIT DISTURBANCE 26 0.0001
601 INFLAMMATION 7 0.0001
602 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
603 BLOOD PRESSURE DECREASED 9 0.0001
604 CATARACT 8 0.0001
605 PULMONARY MASS 2 0.0001
606 RASH PAPULAR 3 0.0001
607 SNEEZING 3 0.0001
608 DERMATITIS ATOPIC 7 0.0001
609 TREMOR 22 0.0001
610 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
611 OSTEOPENIA 2 0.0001
612 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
613 HEART RATE INCREASED 13 0.0001
614 SKIN IRRITATION 6 0.0001
615 DISSOCIATION 1 0.0001
616 SYNCOPE 13 0.0001
617 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
618 FOOD ALLERGY 1 0.0001
619 WEIGHT INCREASED 29 0.0001
620 CONCUSSION 1 0.0001
621 OEDEMA 7 0.0001
622 RENAL DISORDER 6 0.0001
623 APNOEA 1 0.0001
624 SWOLLEN TONGUE 4 0.0001
625 HEADACHE 80 0.0001
626 DRUG-INDUCED LIVER INJURY 4 0.0001
627 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
628 CYANOSIS 2 0.0001
629 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
630 DYSPHAGIA 12 0.0001
631 DIZZINESS 63 0.0001
632 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
633 ILLNESS 13 0.0001
634 BLOOD ALBUMIN DECREASED 1 0.0001
635 SCIATICA 2 0.0001
636 PANCYTOPENIA 7 0.0001
637 NECK PAIN 7 0.0001
638 ABDOMINAL DISCOMFORT 21 0.0001
639 PRURITUS 48 0.0001
640 BLOOD DISORDER 1 0.0001
641 TOXICITY TO VARIOUS AGENTS 21 0.0001
642 PYREXIA 43 0.0001
643 NIGHT SWEATS 4 0.0001
644 ASTHMA 14 0.0001
645 NAUSEA 98 0.0001
646 MENTAL IMPAIRMENT 3 0.0001
647 HYPOGLYCAEMIA 6 0.0001
648 BACK DISORDER 2 0.0001
649 AGITATION 9 0.0001
650 ABNORMAL FAECES 1 0.0001
651 METASTASES TO BONE 2 0.0001
652 IMPAIRED HEALING 4 0.0001
653 HERPES ZOSTER 7 0.0001
654 PRODUCT SUBSTITUTION ISSUE 7 0.0001
655 ESCHERICHIA INFECTION 1 0.0001
656 INFLUENZA LIKE ILLNESS 10 0.0001
657 ABASIA 3 0.0001
658 OSTEONECROSIS OF JAW 3 0.0001
659 PHOTOSENSITIVITY REACTION 2 0.0001
660 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
661 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
662 VIRAL INFECTION 4 0.0001
663 GAIT INABILITY 4 0.0001
664 DYSPHONIA 7 0.0001
665 BONE PAIN 7 0.0001
666 ATRIAL SEPTAL DEFECT 1 0.0001
667 UNEVALUABLE EVENT 9 0.0001
668 HAEMOGLOBIN DECREASED 12 0.0001
669 HYPERHIDROSIS 15 0.0001
670 ANAPHYLACTIC SHOCK 3 0.0001
671 UNRESPONSIVE TO STIMULI 3 0.0001
672 BACK PAIN 27 0.0001
673 MUSCULOSKELETAL DISCOMFORT 2 0.0001
674 HYPOACUSIS 5 0.0001
675 RASH GENERALISED 3 0.0001
676 DIPLOPIA 3 0.0001
677 RESPIRATORY TRACT INFECTION 3 0.0001
678 JOINT STIFFNESS 3 0.0001
679 EOSINOPHILIA 2 0.0001
680 COUGH 32 0.0001
681 BLOOD CALCIUM INCREASED 1 0.0001
682 DEPRESSED MOOD 6 0.0001
683 ANGIOEDEMA 5 0.0001
684 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
685 HEAD DISCOMFORT 2 0.0001
686 DRUG ERUPTION 2 0.0001
687 PAIN IN EXTREMITY 33 0.0001
688 DIARRHOEA 72 0.0001
689 PALPITATIONS 13 0.0001
690 GASTROENTERITIS VIRAL 2 0.0001
691 PERIPHERAL SWELLING 17 0.0001
692 RESTLESS LEGS SYNDROME 2 0.0001
693 HYPERGLYCAEMIA 4 0.0001
694 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
695 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
696 INSOMNIA 29 0.0001
697 BRAIN NEOPLASM 1 0.0001
698 BLOOD GLUCOSE ABNORMAL 2 0.0001
699 DIVERTICULITIS 3 0.0001
700 MENTAL STATUS CHANGES 3 0.0001
701 DECREASED APPETITE 25 0.0001
702 ABDOMINAL PAIN 25 0.0001
703 CHEST DISCOMFORT 11 0.0001
704 BACTERIAL INFECTION 2 0.0001
705 BLISTER 6 0.0001
706 OXYGEN SATURATION DECREASED 6 0.0001
707 FLANK PAIN 1 0.0001
708 DYSPNOEA EXERTIONAL 4 0.0001
709 INTESTINAL OBSTRUCTION 4 0.0001
710 FRACTURE 2 0.0001
711 RASH ERYTHEMATOUS 5 0.0001
712 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
713 ERUCTATION 2 0.0001
714 DYSSTASIA 3 0.0001
715 HYPERSENSITIVITY 19 0.0001
716 CONDITION AGGRAVATED 31 0.0001
717 COELIAC DISEASE 1 0.0001
718 KIDNEY INFECTION 2 0.0001
719 URINARY INCONTINENCE 3 0.0001
720 DISORIENTATION 4 0.0001
721 CONSTIPATION 22 0.0001
722 UPPER LIMB FRACTURE 2 0.0001
723 HYPOAESTHESIA 15 0.0001
724 FEELING ABNORMAL 24 0.0001
725 BLOOD POTASSIUM DECREASED 3 0.0001
726 URINARY TRACT INFECTION 17 0.0001
727 ANAEMIA 19 0.0001
728 CELLULITIS 5 0.0001
729 THERAPEUTIC RESPONSE DECREASED 6 0.0001
730 RASH 43 0.0001
731 FEEDING DISORDER 2 0.0001
732 VERTIGO 6 0.0001
733 BONE MARROW FAILURE 2 0.0001
734 FLUID RETENTION 5 0.0001
735 NEUTROPHIL COUNT DECREASED 4 0.0001
736 BODY TEMPERATURE INCREASED 2 0.0001
737 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
738 CARDIAC ARREST 8 0.0001
739 INFECTION 14 0.0001
740 POLLAKIURIA 4 0.0001
741 MOUTH ULCERATION 2 0.0001
742 HEAD INJURY 3 0.0001
743 HYPOTHYROIDISM 3 0.0001
744 EATING DISORDER 2 0.0001
745 RETCHING 2 0.0001
746 BREAST PAIN 1 0.0001
747 EPISTAXIS 7 0.0001
748 IRRITABLE BOWEL SYNDROME 2 0.0001
749 SKIN CANCER 2 0.0001
750 DRUG EFFECT DECREASED 5 0.0001
751 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
752 BALANCE DISORDER 8 0.0001
753 ATRIAL FIBRILLATION 9 0.0001
754 RASH PRURITIC 5 0.0001
755 BIPOLAR DISORDER 1 0.0001
756 BACK INJURY 1 0.0001
757 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
758 STAPHYLOCOCCAL INFECTION 3 0.0001
759 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
760 FEBRILE NEUTROPENIA 6 0.0001
761 DENTAL CARIES 1 0.0001
762 EXPIRED PRODUCT ADMINISTERED 3 0.0001
763 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
764 LIVER DISORDER 4 0.0001
765 STEVENS-JOHNSON SYNDROME 2 0.0001
766 DRY SKIN 12 0.0001
767 GLOSSODYNIA 2 0.0001
768 GASTROINTESTINAL DISORDER 8 0.0001
769 ADVERSE DRUG REACTION 8 0.0001
770 BLOOD CALCIUM DECREASED 1 0.0001
771 CHROMATURIA 2 0.0001
772 DYSPNOEA 50 0.0001
773 HAEMATURIA 3 0.0001
774 CHOLECYSTECTOMY 1 0.0001
775 NEPHROLITHIASIS 4 0.0001
776 TINNITUS 4 0.0001
777 MUSCLE TWITCHING 2 0.0001
778 WEIGHT DECREASED 24 0.0001
779 RASH MACULAR 3 0.0001
780 HYPOXIA 3 0.0001
781 DRUG INEFFECTIVE 112 0.0001
782 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
783 ANXIETY 24 0.0001
784 BLOOD IRON DECREASED 1 0.0001
785 BACTERAEMIA 1 0.0001
786 FALL 28 0.0001
787 PRODUCT ADHESION ISSUE 3 0.0001
788 THERAPY INTERRUPTED 6 0.0001
789 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
790 LOCALISED INFECTION 2 0.0001
791 CEREBRAL INFARCTION 2 0.0001
792 CYTOPENIA 1 0.0001
793 DYSPEPSIA 8 0.0001
794 VOMITING 38 0.0001
795 VISUAL IMPAIRMENT 10 0.0001
796 INJECTION SITE ERYTHEMA 10 0.0001
797 CYST 1 0.0001
798 CONFUSIONAL STATE 13 0.0001
799 HEPATIC FUNCTION ABNORMAL 3 0.0001
800 HYPERTENSION 17 0.0001
801 PNEUMONIA ASPIRATION 2 0.0001
802 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
803 ABDOMINAL PAIN LOWER 2 0.0001
804 URTICARIA 13 0.0001
805 ANOREXIA 1 0.0001
806 RHINORRHOEA 5 0.0001
807 HAEMATOMA 2 0.0001
808 EXPOSURE VIA SKIN CONTACT 2 0.0001
809 PRODUCT DOSE OMISSION 5 0.0001
810 MUCOSAL INFLAMMATION 2 0.0001
811 APPLICATION SITE ERYTHEMA 2 0.0001
812 ANHEDONIA 2 0.0001
813 ADVERSE EVENT 7 0.0001
814 DEPRESSION 17 0.0001
815 MENSTRUATION IRREGULAR 2 0.0001
816 SOMNOLENCE 15 0.0001
817 DISTURBANCE IN ATTENTION 4 0.0001
818 PNEUMONIA 24 0.0001
819 FREQUENT BOWEL MOVEMENTS 2 0.0001
820 DYSKINESIA 3 0.0001
821 PNEUMONITIS 2 0.0001
822 DRUG TOXICITY 1 0.0001
823 AKATHISIA 1 0.0001
824 ACUTE HEPATIC FAILURE 1 0.0001
825 MALAISE 32 0.0001
826 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
827 APPLICATION SITE RASH 1 0.0001
828 RESPIRATORY ARREST 2 0.0001
829 CARDIO-RESPIRATORY ARREST 3 0.0001
830 ROAD TRAFFIC ACCIDENT 3 0.0001
831 COORDINATION ABNORMAL 1 0.0001
832 WOUND 2 0.0001
833 SKIN EXFOLIATION 6 0.0001
834 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
835 BLINDNESS UNILATERAL 1 0.0001
836 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
837 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
838 LOSS OF CONSCIOUSNESS 9 0.0001
839 MOBILITY DECREASED 5 0.0001
840 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
841 ANOSMIA 1 0.0001
842 MENTAL DISORDER 3 0.0001
843 SURGERY 4 0.0001
844 DISEASE PROGRESSION 8 0.0001
845 WHEEZING 4 0.0001
846 DYSGEUSIA 5 0.0001
847 PULMONARY OEDEMA 3 0.0001
848 RESPIRATORY DISORDER 2 0.0001
849 PRODUCT QUALITY ISSUE 9 0.0001
850 NEUTROPENIA 9 0.0001
851 ECONOMIC PROBLEM 1 0.0001
852 ILL-DEFINED DISORDER 4 0.0001
853 PLEURAL EFFUSION 4 0.0001
854 DIABETES MELLITUS 5 0.0001
855 MEMORY IMPAIRMENT 9 0.0001
856 DRUG DISPENSING ERROR 1 0.0001
857 ACUTE KIDNEY INJURY 10 0.0001
858 FEELING HOT 4 0.0001
859 DRUG ADMINISTRATION ERROR 2 0.0001
860 DEVICE RELATED INFECTION 1 0.0001
861 PRODUCT DOSE OMISSION ISSUE 19 0.0001
862 ANKLE FRACTURE 1 0.0001
863 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
864 ACUTE MYELOID LEUKAEMIA 1 0.0001
865 BASAL CELL CARCINOMA 1 0.0001
866 ABSCESS 1 0.0001
867 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
868 BLOOD POTASSIUM INCREASED 1 0.0001
869 AMNESIA 4 0.0001
870 INCORRECT DOSE ADMINISTERED 14 0.0001
871 CHOLELITHIASIS 2 0.0001
872 OSTEONECROSIS 2 0.0001
873 RENAL FAILURE 8 0.0001
874 LEUKOPENIA 3 0.0001
875 NEOPLASM MALIGNANT 4 0.0001
876 HYPOTENSION 12 0.0001
877 INJECTION SITE PRURITUS 4 0.0001
878 CANDIDA INFECTION 1 0.0001
879 ANGER 2 0.0001
880 INJECTION SITE PAIN 18 0.0001
881 GASTRIC DISORDER 2 0.0001
882 INJECTION SITE REACTION 4 0.0001
883 DELIRIUM 2 0.0001
884 HAEMORRHAGE 6 0.0001
885 MUSCULOSKELETAL PAIN 3 0.0001
886 HEART RATE DECREASED 2 0.0001
887 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
888 TACHYCARDIA 5 0.0001
889 SKIN BURNING SENSATION 4 0.0001
890 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
891 C-REACTIVE PROTEIN INCREASED 2 0.0001
892 BONE DISORDER 1 0.0001
893 TREATMENT NONCOMPLIANCE 3 0.0001
894 RESTLESSNESS 2 0.0001
895 HAEMATOCHEZIA 3 0.0001
896 DYSURIA 2 0.0001
897 ANAPHYLACTIC REACTION 3 0.0001
898 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
899 THROMBOCYTOPENIA 6 0.0001
900 PSORIASIS 7 0.0001
901 HYPONATRAEMIA 3 0.0001
902 RHEUMATOID ARTHRITIS 6 0.0001
903 COLITIS 2 0.0001
904 ACNE 4 0.0001
905 DEHYDRATION 7 0.0001
906 MIGRAINE 5 0.0001
907 PLASMA CELL MYELOMA 2 0.0001
908 CHOKING 1 0.0001
909 DISABILITY 1 0.0001
910 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
911 INJECTION SITE HAEMORRHAGE 4 0.0001
912 ABORTION SPONTANEOUS 2 0.0000
913 CYTOKINE RELEASE SYNDROME 1 0.0000
914 STOMATITIS 3 0.0000
915 FLUSHING 5 0.0000
916 LUNG NEOPLASM MALIGNANT 2 0.0000
917 CHEST PAIN 9 0.0000
918 TREATMENT FAILURE 4 0.0000
919 PRODUCT USE ISSUE 9 0.0000
920 DERMATITIS 1 0.0000
921 RENAL IMPAIRMENT 4 0.0000
922 DEEP VEIN THROMBOSIS 3 0.0000
923 DEVICE DISLOCATION 2 0.0000
924 BLOOD CREATININE INCREASED 3 0.0000
925 INFLUENZA 5 0.0000
926 THROAT IRRITATION 2 0.0000
927 APPLICATION SITE PRURITUS 1 0.0000
928 HEPATIC ENZYME INCREASED 3 0.0000
929 BLOOD CHOLESTEROL INCREASED 2 0.0000
930 COGNITIVE DISORDER 2 0.0000
931 INJURY 3 0.0000
932 PULMONARY EMBOLISM 4 0.0000
933 DISEASE RECURRENCE 2 0.0000
934 OEDEMA PERIPHERAL 5 0.0000
935 ENCEPHALOPATHY 1 0.0000
936 EXTRAPYRAMIDAL DISORDER 1 0.0000
937 CHRONIC KIDNEY DISEASE 3 0.0000
938 THERAPY CESSATION 2 0.0000
939 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
940 NERVOUSNESS 2 0.0000
941 ECZEMA 2 0.0000
942 DRUG INTERACTION 6 0.0000
943 BREAST CANCER FEMALE 1 0.0000
944 CARDIAC FAILURE 3 0.0000
945 BLOOD BILIRUBIN INCREASED 1 0.0000
946 DRUG DOSE OMISSION 6 0.0000
947 ABNORMAL DREAMS 1 0.0000
948 MEDICATION ERROR 2 0.0000
949 SEPSIS 4 0.0000
950 CEREBROVASCULAR ACCIDENT 6 0.0000
951 ANGINA PECTORIS 1 0.0000
952 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
953 PRODUCT STORAGE ERROR 3 0.0000
954 DRUG WITHDRAWAL SYNDROME 3 0.0000
955 NASAL CONGESTION 2 0.0000
956 ASCITES 1 0.0000
957 EMOTIONAL DISTRESS 4 0.0000
958 SUICIDAL IDEATION 3 0.0000
959 EPILEPSY 1 0.0000
960 EMOTIONAL DISORDER 1 0.0000
961 FEMUR FRACTURE 1 0.0000
962 EXPOSURE DURING PREGNANCY 2 0.0000
963 BONE DENSITY DECREASED 1 0.0000
964 BLOOD GLUCOSE INCREASED 6 0.0000
965 CYSTITIS 1 0.0000
966 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
967 PLATELET COUNT DECREASED 3 0.0000
968 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
969 DRUG EFFECT INCOMPLETE 1 0.0000
970 CRYING 1 0.0000
971 HOSPITALISATION 4 0.0000
972 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
973 CARDIAC FAILURE CONGESTIVE 2 0.0000
974 PROSTATE CANCER 2 0.0000
975 EXTRA DOSE ADMINISTERED 1 0.0000
976 OVERDOSE 5 0.0000
977 MYOCARDIAL INFARCTION 4 0.0000
978 ARRHYTHMIA 1 0.0000
979 COMA 1 0.0000
980 COLORECTAL CANCER 1 0.0000
981 DRUG INTOLERANCE 2 0.0000
982 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
983 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
984 CONVULSION 1 0.0000
985 SEIZURE 2 0.0000
986 DRUG DEPENDENCE 2 0.0000
987 DRUG ABUSE 1 0.0000
988 DEATH 6 0.0000